This specialized case study explores Kymanox’s approach to regulatory strategy and Quality Management System (QMS) establishment for a pioneering 3D-printed cartilage implant addressing microtia. Our team of SMEs collaborated closely with stakeholders to implement measurable improvements across regulatory pathway definition, design control, and QMS support, facilitating successful product development and commercialization.
CHALLENGE
SOLUTION
RESULTS
- A Client is developing a 3D-printed cartilage implant for microtia, an ultra-rare external ear condition, involving autologous cartilage cells within a biopolymer matrix.
- Ensure the implant met regulatory compliance requirements for medical devices.
- Establish a Quality Management System (QMS) to support manufacturing and commercialization of the implant.
- Defined the product’s regulatory pathway to satisfy applicable compliance standards.
- Executed design control processes, including authoring the Design History File (DHF) covering design transfer and manufacturing support.
- Assisted in the creation and implementation of a compliant QMS tailored for medical device production.
- Successfully navigated complex regulatory frameworks to advance the novel 3D-printed implant toward manufacturing and commercialization.
- Delivered comprehensive technical documentation supporting regulatory submissions and operational readiness.
- Established a robust QMS enabling sustained compliance and ongoing product quality assurance.